Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

2.

Development of a Standard Reference Material for metabolomics research.

Phinney KW, Ballihaut G, Bedner M, Benford BS, Camara JE, Christopher SJ, Davis WC, Dodder NG, Eppe G, Lang BE, Long SE, Lowenthal MS, McGaw EA, Murphy KE, Nelson BC, Prendergast JL, Reiner JL, Rimmer CA, Sander LC, Schantz MM, Sharpless KE, Sniegoski LT, Tai SS, Thomas JB, Vetter TW, Welch MJ, Wise SA, Wood LJ, Guthrie WF, Hagwood CR, Leigh SD, Yen JH, Zhang NF, Chaudhary-Webb M, Chen H, Fazili Z, LaVoie DJ, McCoy LF, Momin SS, Paladugula N, Pendergrast EC, Pfeiffer CM, Powers CD, Rabinowitz D, Rybak ME, Schleicher RL, Toombs BM, Xu M, Zhang M, Castle AL.

Anal Chem. 2013 Dec 17;85(24):11732-8. doi: 10.1021/ac402689t. Epub 2013 Dec 3.

PMID:
24187941
3.

An assessment of 25-hydroxyvitamin D measurements in comparability studies conducted by the Vitamin D Metabolites Quality Assurance Program.

Bedner M, Lippa KA, Tai SS.

Clin Chim Acta. 2013 Nov 15;426:6-11. doi: 10.1016/j.cca.2013.08.012. Epub 2013 Aug 24.

4.

In Reply.

Vesper HW, Botelho JC, Tai SS, Van Uytfanghe K, Thienpont LM.

Clin Chem. 2013 Jul;59(7):1130-1. No abstract available.

5.

A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients.

Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL.

Transplantation. 2013 May 27;95(10):1233-41. doi: 10.1097/TP.0b013e318291a269.

PMID:
23689085
6.

The development and implementation of quality assurance programs to support nutritional measurements.

Sander LC, Bedner M, Duewer DL, Lippa KA, Phillips MM, Phinney KW, Rimmer CA, Schantz MM, Sharpless KE, Tai SS, Thomas JB, Wise SA, Wood LJ, Betz JM, Coates PM.

Anal Bioanal Chem. 2013 May;405(13):4437-41. doi: 10.1007/s00216-013-6864-7. Epub 2013 Apr 4.

PMID:
23552970
7.

Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum.

Botelho JC, Shacklady C, Cooper HC, Tai SS, Van Uytfanghe K, Thienpont LM, Vesper HW.

Clin Chem. 2013 Feb;59(2):372-80. doi: 10.1373/clinchem.2012.190934. Epub 2012 Dec 4.

8.

Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency.

Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S.

Am J Transplant. 2012 Sep;12(9):2487-97. doi: 10.1111/j.1600-6143.2012.04131.x. Epub 2012 Jul 9.

9.

Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer.

Campbell SB, Walker R, Tai SS, Jiang Q, Russ GR.

Am J Transplant. 2012 May;12(5):1146-56. doi: 10.1111/j.1600-6143.2012.04004.x. Epub 2012 Mar 15.

10.

Development and certification of a standard reference material for vitamin D metabolites in human serum.

Phinney KW, Bedner M, Tai SS, Vamathevan VV, Sander LC, Sharpless KE, Wise SA, Yen JH, Schleicher RL, Chaudhary-Webb M, Pfeiffer CM, Betz JM, Coates PM, Picciano MF.

Anal Chem. 2012 Jan 17;84(2):956-62. doi: 10.1021/ac202047n. Epub 2011 Dec 28.

11.

Preparation and value assignment of standard reference material 968e fat-soluble vitamins, carotenoids, and cholesterol in human serum.

Thomas JB, Duewer DL, Mugenya IO, Phinney KW, Sander LC, Sharpless KE, Sniegoski LT, Tai SS, Welch MJ, Yen JH.

Anal Bioanal Chem. 2012 Jan;402(2):749-62. doi: 10.1007/s00216-011-5447-8. Epub 2011 Oct 21.

PMID:
22015475
13.

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.

Flechner SM, Glyda M, Cockfield S, Griny├│ J, Legendre Ch, Russ G, Steinberg S, Wissing KM, Tai SS.

Am J Transplant. 2011 Aug;11(8):1633-44. doi: 10.1111/j.1600-6143.2011.03573.x. Epub 2011 Jun 10. Erratum in: Am J Transplant. 2012 Jan;12(1):268.

14.

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians.

Suriapranata IM, Tjong WY, Wang T, Utama A, Raharjo SB, Yuniadi Y, Tai SS.

BMC Med Genet. 2011 Jun 6;12:80. doi: 10.1186/1471-2350-12-80.

15.

Murine tyrosinase inhibitors from Cynanchum bungei and evaluation of in vitro and in vivo depigmenting activity.

Ding HY, Chang TS, Shen HC, Tai SS.

Exp Dermatol. 2011 Sep;20(9):720-4. doi: 10.1111/j.1600-0625.2011.01302.x. Epub 2011 May 25.

PMID:
21615508
16.

[Reform of collective forest property in Liaoning Province: a discussion].

Tai SS, Hu YM, Zhang HS, Han YK, Xiao ZC.

Ying Yong Sheng Tai Xue Bao. 2010 May;21(5):1196-200. Chinese.

PMID:
20707101
17.

Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimus.

Tedesco-Silva H, Garcia VD, Contieri FL, De Boni Monteiro de Carvalho D, Noronha IL, Gon├žalves RT, de Paula FJ, Abbud-Filho M, Manfro RC, David-Neto E, Alfieri F, Ikehara E, Jiang Q, Tai SS, Medina-Pestana JO.

Transplant Proc. 2010 Jun;42(5):1659-66. doi: 10.1016/j.transproceed.2010.02.083.

PMID:
20620495
18.

Certification of drugs of abuse in a human serum standard reference material: SRM 1959.

Tai SS, Prendergast JL, Sniegoski LT, Welch MJ, Phinney KW, Zhang NF.

Anal Bioanal Chem. 2010 May;397(2):501-9. doi: 10.1007/s00216-010-3603-1. Epub 2010 Mar 24.

PMID:
20333365
20.

Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers.

Tai SS, Lin CG, Wu MH, Chang TS.

Int J Mol Sci. 2009 Nov 20;10(10):4257-66. doi: 10.3390/ijms10104257.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk